WSP works closely with our pharmaceutical and biotechnology clients globally, reacting to their challenges, and advising on international best practice.

 Our extensive portfolio of research facilities, pharmaceutical plants, formulation and dosage facilities and medical projects meet the stringent requirements of the pharmaceutical and biotechnology industry. Our rigorous approach has earned the trust of multinational clients such as GSK and Astra Zeneca, as well our local clients, with whom we work on anything from production plants, warehousing and logistics to infrastructure and support facilities.

We are able to add value at all stages of your project, meeting FDA, Health Canada, EU and global regulations, from research and pre-project analysis to site master planning, detail engineering, construction management and commercial realisation. 

When you have secured capital funding, we can put together a multidisciplinary team to deliver a full Engineering, Procurement, Construction Management, and Validation (EPCMV) offering. Our international presence enables us to build you the best project team using our consultants and engineers from our Pharmaceutical Process Engineering Centre of Excellence and other global pharmaceutical hubs. Our industry leaders and our local experts can integrate with your team to ensure complete collaboration with your supply chain.

Our pharmaceutical support does not end when a capital project is completed: we have teams of engineers who work constantly on site, providing both operational and business improvement services. Not only do we deliver this support using alliance partnerships to ensure that you get the highest level of flexibility and value, we also provide the ongoing benefits of our international pharmaceutical expertise applied at site level.

Our extensive portfolio of projects has encompassed design, engineering, project management, construction, and consultancy for:

• Research and development facilities
• Laboratories
• High-level containment laboratories
• Production and packaging facilities
• Formulation and dosage facilities 
• Warehousing and logistics
• Infrastructure and support facilities
• Flexible facilities
• Medical devices
• Process intensification, process modelling, and facility improvements

Industry Recognition

Our expertise has been recognized by world-leading institutions :

• The International Society of Pharmaceutical Engineers (ISPE), Facility of the Year 2013 Award for the Equipment Innovation for the Med-Immune Automation Upgrade project.
• European Construction Institute (ECI), Case Study Project of the Year 2012: we delivered value-enhancing practice using ECI-ACTIVE principles for the effective storage of Pfizer’s high-value pharmaceutical products.